BC Innovations | Jun 7, 2012
Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Prostate cancer Myeloid/lymphoid or mixed-lineage leukemia 2 (MLL2) Patient sample and cell culture studies suggest inhibiting MLL2 could help treat prostate...
BC Innovations | Jan 20, 2011
Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Brain cancer Myeloid/lymphoid or mixed-lineage leukemia 2 (MLL2); MLL3 A genomic study suggests that agonizing the histone methyltransferases MLL2 or MLL3...
Items per page:
1 - 2 of 2